Student Presentation Day is underway! Today we'll hear from our 3rd year PhD students about their research and select the finalists for the Ita Askonas Prize 2024 🏅 MRC MHU | MRC TIDU | RDM Oxford | Department of Paediatrics | OxfordOncology | Nuffield Department of Clinical Neurosciences

It was wonderful to see the Seminar Room so busy yesterday for our Student Presentation Day! Congratulations to everyone who presented, especially Elizabeth Horton (Rehwinkel Group), Isaac Walton (Wilkie Lab) and Joseph Hamley (jdavieslab) who have been shortlisted for the

Huge congratulations to Prof Adam Mead, who was elected as a Fellow of the Academy of Medical Sciences (Academy of Medical Sciences) last week 🎉

Our group focuses on the origins of high risk #ChildhoodALL. Much to do for these children and their families. #WorldBloodCancerDay MRC MHU Oxford Cancer Science and Innovation at Cancer Research UK The Azaylia Foundation Wellcome Little Princess Trust Children’s Cancer and Leukaemia Group Leukaemia UK Children with Cancer UK Great Ormond Street Hospital Charity

Congratulations to Prof andi roy, who is one of the recipients of Cancer Research UK's new Data for Children’s and Young People’s Cancer Pilot Award 🥳

Wonderful to have Veronica's Cell sculpture in the MRC WIMM ❤️ Veronica Buckle joined the MRC MHU in 1987 and contributed to many different projects in molecular medicine during her time as a group leader 🔬

📆1 week left to apply! We have an exciting opportunity to join our Core Admin team as Deputy Business Manager. Find out more & apply here: bit.ly/3VfkcPZ Reporting directly to the Institute Administrator, you will be responsible for the day-to-day management of the

Don't forget to sign up for the 1st SRF Conference in September, organised by our very own Michalina Mazurczyk as part of her role as a Technician Champion! Find out more: pod.web.ox.ac.uk/event/universi…

Research fellow Abdullah Khan (Abdullah Khan) discusses his research on TheScientistsChannel:

NEW: Study published in Cell Stem Cell by Vyas Lab, with the Dick and Xie labs at Princess Margaret Cancer Centre, uncovers key details of clonal outgrowth in blood cells with ageing. Read more: bit.ly/45D3b74 Congrats to Asger Jakobsen, Sven Turkalj, paresh vyas & all authors!

Reflecting on WIMM Day 2024: imm.ox.ac.uk/news/wimm-day-… Congratulations again to those who received awards and thank you to all who attended for another fantastic day of sharing science and connecting our community 🤝

NEW SPINOUT: Yellowstone Biosciences has launched to pioneer new cancer treatments using advanced T-cell therapies based on research from co-founder & MRC MHU Deputy Director paresh vyas (Vyas Lab) Find out more: bit.ly/3Y36kLP

It was a beautifully sunny afternoon for the first outing of the #WIMMWombles - our new monthly lunchtime litter picking club!

EVENT: Scientific Research Facilities Conference Save the date for the 1st University of Oxford SRF Conference at the Medical Sciences Teaching Centre. Join for a wide review of facilities' expertise, equipment, and services. 🗓️Sep 26-27 Free registration👇 pod.web.ox.ac.uk/event/universi…

NEW preprint from Hughes Group & Watkins labs:

New NatureStructMolBiol paper from Ross Chapman uncovers DNA repair mechanism which can lead to the initiation and evolution of BRCA1 mutant cancers, which include around half of all inherited cases of breast & ovarian cancer. nature.com/articles/s4159… Nuffield Department of Medicine Centre for Human Genetics

NEW collaborative study out from the Vyas Lab in the Journal of Clinical Oncology (Journal of Clinical Oncology) on improving risk stratification for older patients diagnosed with Acute Myeloid Leukemia (AML):

Looking back on the 2024 MRC WIMM Work Experience Placements 📽️ Last month we hosted 5 students through In2scienceUK's In2STEM programme. For 2 weeks, these students got to experience life in a research lab and learn all about the great science happening in our institute.

NEW: An international collaboration led by paresh vyas and Peter Valk (Erasmus MC Intl) has created a tool to help clinicians predict how older patients with acute myeloid leukaemia will respond to treatment. Read more: imm.ox.ac.uk/news/AML60